PE-backed Algorithme Pharma Buys Bioanalytical Systems Carve-Out

Algorithme Pharma, backed by PE firm Kilmer Capital Partners, purchased the clinical pharmacology research unit of Bioanalytical Systems Inc. The Baltimore location is the Quebec-based company's first entrance in the US market. The company provides services for bioequivalence and Phase I studies to the generic, pharmaceutical, and bio-technology industries.